Shrinking the Malaria Map

UCSF Global Health Group’s Malaria Elimination Initiative (MEI)

Safety of single dose primaquine in G6PD-deficient and G6PD-normal males in Mali without malaria: an open-label, phase 1, dose-adjustment trial

January 2018

Safety of single dose primaquine in G6PD-deficient and G6PD-normal males in Mali without malaria: an open-label, phase 1, dose-adjustment trial

Chen I, Diawara H, Mahamar A, Sanogo K, Keita S, Kone DT, Diarra K, Djimde M, Keita M, Brown JM, Roh ME, Hwang J, Pett H, Murphy M, Niemi M, Greenhouse B, Bousema T, Gosling R, Dicko A
Peer Reviewed Publication
Published by:
The Journal of Infectious Diseases